Dennis J. Carlo
2016
In 2016, Dennis J. Carlo earned a total compensation of $1.8M as President and Chief Executive Officer at Adamis Pharmaceuticals, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $143,750 |
|---|---|
| Option Awards | $1,017,444 |
| Salary | $575,000 |
| Other | $27,527 |
| Total | $1,763,721 |
Carlo received $1M in option awards, accounting for 58% of the total pay in 2016.
Carlo also received $143.8K in non-equity incentive plan, $575K in salary and $27.5K in other compensation.
Rankings
In 2016, Dennis J. Carlo's compensation ranked 5,474th out of 14,075 executives tracked by ExecPay. In other words, Carlo earned more than 61.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,474 out of 14,075 | 61st |
Division Manufacturing | 1,965 out of 5,486 | 64th |
Major group Chemicals And Allied Products | 622 out of 1,900 | 67th |
Industry group Drugs | 465 out of 1,543 | 70th |
Industry Pharmaceutical Preparations | 369 out of 1,173 | 69th |
Source: SEC filing on June 7, 2018.
Carlo's colleagues
We found two more compensation records of executives who worked with Dennis J. Carlo at Adamis Pharmaceuticals in 2016.